Hiderou Yoshida

Hiderou Yoshida

University of Hyogo

H-index: 47

Asia-Japan

About Hiderou Yoshida

Hiderou Yoshida, With an exceptional h-index of 47 and a recent h-index of 33 (since 2020), a distinguished researcher at University of Hyogo, specializes in the field of Cell Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

The cholesterol pathway of the Golgi stress response induces cell death and transcription of Golgi-related genes through metabolic dysregulation of phosphatidylinositol-4-phosphate

Expression of transcription factors KLF2 and KLF4 is induced by the mammalian Golgi stress response

EE63 Cost-Effectiveness of Olaparib Plus Bevacizumab First-Line Maintenance in Ovarian Cancer Alongside the PAOLA-1 Trial

786P Antitumor activity of farletuzumab ecteribulin in a panel of endometrial cancer patient-derived xenografts with four different molecular subtypes

Phosphorylation of EIF2S1 (eukaryotic translation initiation factor 2 subunit alpha) is indispensable for nuclear translocation of TFEB and TFE3 during ER stress

Signal sequence-triage is activated by translocon obstruction sensed by an ER stress sensor IRE1α

HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma

LBA29 Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly …

Hiderou Yoshida Information

University

Position

___

Citations(all)

23940

Citations(since 2020)

6393

Cited By

36702

hIndex(all)

47

hIndex(since 2020)

33

i10Index(all)

75

i10Index(since 2020)

52

Email

University Profile Page

University of Hyogo

Google Scholar

View Google Scholar Profile

Hiderou Yoshida Skills & Research Interests

Cell Biology

Top articles of Hiderou Yoshida

Title

Journal

Author(s)

Publication Date

The cholesterol pathway of the Golgi stress response induces cell death and transcription of Golgi-related genes through metabolic dysregulation of phosphatidylinositol-4-phosphate

bioRxiv

Kanae Sasaki

Takuya Adachi

Fumi Morishita

Marika Toide

Yuto Watanabe

...

2023

Expression of transcription factors KLF2 and KLF4 is induced by the mammalian Golgi stress response

bioRxiv

Kanae Sasaki

Miyu Sakamoto

Iona Miyake

Reishi Tanaka

Ryuya Tanaka

...

2023

EE63 Cost-Effectiveness of Olaparib Plus Bevacizumab First-Line Maintenance in Ovarian Cancer Alongside the PAOLA-1 Trial

L Perrier

K Zarca

T Cadet

M Morelle

C Cropet

...

2023/12/1

786P Antitumor activity of farletuzumab ecteribulin in a panel of endometrial cancer patient-derived xenografts with four different molecular subtypes

Annals of Oncology

K Hasegawa

S Yagishita

D Shintani

H Yoshida

M Suzuki

...

2023/10/1

Phosphorylation of EIF2S1 (eukaryotic translation initiation factor 2 subunit alpha) is indispensable for nuclear translocation of TFEB and TFE3 during ER stress

Autophagy

Thao Thi Dang

Mi-Jeong Kim

Yoon Young Lee

Hien Thi Le

Kook Hwan Kim

...

2023/7/3

Signal sequence-triage is activated by translocon obstruction sensed by an ER stress sensor IRE1α

Cell Structure and Function

Ashuei Sogawa

Ryota Komori

Kota Yanagitani

Miku Ohfurudono

Akio Tsuru

...

2023

HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma

Chiharu Mizoguchi

Tadaaki Nishikawa

Hiroshi Yoshida

Kasumi Yamamoto

Rui Kitadai

...

2022/12/21

LBA29 Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly …

Annals of Oncology

IL Ray-Coquard

A Leary

S Pignata

C Cropet

AJ Gonzalez Martin

...

2022/9/1

P-384 Efficacy of endometrial microbiome metagenomic analysis with recurrent implantation failure and recurrent pregnancy loss: multicenter study in Japan

Human Reproduction

N Iwami

S Komiya

Y Asada

K Tatsumi

T Habara

...

2022/7/1

Förster resonance energy transfer (FRET) nanoprobe could diagnose pancreatic juice activation due to postoperative pancreatic fistula

HPB

S Mizutani

M Murata

H Furuki

R Nakata

N Taniai

...

2021/1/1

1767P Co-clinical PDX study of trastuzumab deruxtecan in HER2-positive uterine carcinosarcoma (STATICE trial, NCCH1615)

Annals of Oncology

S Yagishita

T Nishikawa

H Yoshida

D Shintani

S Sato

...

2021/9/1

813P efficacy and safety of trastuzumab deruxtecan in HER2-expressing uterine carcinosarcoma (STATICE trial, NCCH1615): a multicenter, phase II clinical trial

Annals of Oncology

K Hasegawa

T Nishikawa

A Hirakawa

M Kawasaki

S Tomatsuri

...

2021/9/1

739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged≥ 65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial

Annals of oncology

Renaud Sabatier

F Rousseau

F Joly

C Cropet

C Montegut

...

2021/9/1

FP07. 04 Predictive Efficacy of Morphological Biomarkers Based on Digital Pathology for ICI Therapy of Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

N Motoi

H Yoshida

T Kiyuna

H Saiga

H Horinouchi

...

2021/3/1

Snowmass2021-Letter of Interest Ocean Bottom Detector

snowmass loi

H Watanabe

K Inoue

T Sakai

WF McDonough

N Abe

...

2021

P-283 Analysis of KRAS mutation allele in circulating cell-free DNA derived from urine in colorectal cancer patients

Annals of Oncology

R Ohta

T Yamada

S Shinji

A Matsuda

G Takahashi

...

2020/7/1

See List of Professors in Hiderou Yoshida University(University of Hyogo)